Modeling human neurological disorders with induced pluripotent stem cells.

Area of Science:

• Stem cell biology
• Neuroscience
• Regenerative medicine

Background:

• Human induced pluripotent stem (iPS) cells are generated via reprogramming technology.
• iPS cells hold promise for regenerative medicine, disease modeling, and drug development.
• Patient-specific iPS cells allow for in vitro construction of disease models with genetic information.

Purpose of the Study:

• To review the progress of patient-derived iPS cells in modeling neurological disorders.
• To discuss the application of iPS cells in testing existing drugs and discovering new ones.
• To highlight recent advancements and knowledge in neurological disease-specific iPS cell research.

Main Methods:

• Reprogramming somatic cells into iPS cells.
• Differentiating iPS cells into specific cell types (neurons, cardiomyocytes, etc.).
• Multi-omics analysis of patient-derived neural cells.
• Large-scale screening of chemical libraries using disease-specific iPS cells.
• Gene-editing technologies applied to iPS cells.

Main Results:

• Established iPS cell lines from patients with neuropsychiatric and neurodegenerative diseases.
• Enabled elucidation of pathogenic mechanisms for previously unknown neurological diseases.
• Facilitated in vitro disease modeling with patient-specific genetic information.
• Current drug screening efforts are underway, with expectations for new drug discovery.

Conclusions:

• Patient-derived iPS cells are crucial for in vitro modeling of neurological disorders.
• Innovations in gene editing further enhance the study of disease mechanisms.
• iPS cell technology is advancing drug discovery and regenerative medicine for intractable neurological conditions.